Acumen Research and Consulting estimates that global plasma therapy market is expected to reach the market value of around US$ 400 Mn by 2027 and is anticipated to grow at a CAGR of around 15% in terms of revenue during the forecast period 2020 – 2027.
Blood plasma comprises autologous platelets, platelets and cytokines which stimulate healing of soft tissue. It is commonly used in the dental, dermatological and orthopedic areas. For wound repair, androgenetic alopecia and facial rejuvenation, plasma treatment is widely used. Plasma focuses on the physiological benefit up to 3-5 times and is then injected into tissues where it is required for healing. Plasma also combines advanced medicine technology with body healing power and is used in a wide range of therapeutic applications, such as orthopedics, ophthalmological, neurosrurgical, surgical, and other medicinal procedures. Plasma therapy requires the processing and insertion into a centrifuge of a small amount of a particular blood for platelets and other materials. The platelet is then inserted into and around the injury point for quicker healing. As the blood of the patient is used in the procedure, there is virtually no chance of contamination and allergic reactions to the recipient
The report provides analysis of global plasma therapy market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2019 is considered as the base year.
High demand for least intrusive therapies is anticipated to be correlated with orthopedic diseases of age and trauma, which can, in addition, fuel the worldwide development of plasma therapy. As a result, there has been growing demand for PRP in dental, dermatological, orthopaedic, heart and nerve injuries. Increased orthopedic disorders like arthritis and increasing spending on healthcare are projected to foster global business growth. With a remarkable technical progress over the time, treatments for multiple diseases have also improved dramatically, leading to the implementation of cost-effective plasma protein splitting technology. It is also regarded as a significant boost for plasma therapy demand growth during the forecast phase. Growing variety of patients with androgenic alopecia across the globe and rising athlete injury levels will drive future global demand development. In addition, the growing use of plasma rich in platelets in many clinical fields has a positive effect on the global demand of plasma therapy. However, the lack of knowledge about platelet-rich therapy, the lack of recovery and stringent regulatory policies, however, are limiting global market growth.
North America held the largest market share in overall market in 2019. The rise is largely due to expanded federal funding for plasma therapy advances. Moreover, rising elderly people are encouraging growth on the world economy. Asia Pacific raises higher, taking in the largest chunk of the market. The increase in global plasma-therapy industry in Asia Pacific is responsible for growing disposable patient incomes, medical tourism and practitioners' awareness towards health care. Other considerations include technical advancement and increased policy support for plasma protein medicines production. The rise in Asia-Pacific region is expected to drive growing number of cosmetic operations to improve facial characteristics in countries such as Korea, Thailand and India. In fact, the expanded use of plasma therapy in the area is anticipated to improve the medical tourism industry in the country.
Also the government bodies of developing countries such as India, Mexico, and Brazil, are making huge investments to spread awareness regarding plasma therapy.
The market research study on “Plasma Therapy Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers a detailed insights on the global Plasma Therapy market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report covers global Plasma Therapy market size, and segment markets by type, application, and geography along with the information on companies operating in the market. The Plasma Therapy market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
The global Plasma Therapy market is segmented as below:
Plasma Therapy Market By Source
Plasma Therapy Market By Type
Plasma Therapy Market By Application
Cardiac Muscle Injury
Plasma Therapy Market By End USer
Plasma Therapy Market By Geography
Middle East & Africa
Key Players and Market Situation
Participants include major global players such Bio Products Laboratory Ltd., Cambryn Biologics LLC, Kedrion S.p.A., Octapharma, CSL Ltd, China Biologic Products, Inc., BioLife Plasma Services, LFB S.A., and Grifols International S.A. and Others.
Acumen Research and Consulting predict that the plasma therapy market value is expected to hit around US$ 400 Mn in 2027.
The plasma therapy market is anticipated to grow around 15% CAGR amid the forecast period 2020-2027.
The growing orthopedic diseases is a key driver of the market.
Participants include major global players in plasma therapy market such as Bio Products Laboratory Ltd., Cambryn Biologics LLC, Kedrion S.p.A., Octapharma, CSL Ltd, China Biologic Products, Inc., BioLife Plasma Services, LFB S.A., and Grifols International S.A. and Others.
Leukocyte-Rich Fibrin, Pure Platelet-Rich Fibrin, Leukocyte-Rich Prp, and Pure Prp are the types of plasma therapy market?
North America held the largest market share in plasma therapy market in 2019.
The increase in global plasma-therapy industry in Asia Pacific is responsible for growing disposable patient incomes, medical tourism and practitioners' awareness towards health care.